Monday, April 4, 2016

BRIEF-Cancer metabolism company Metabomed completes $18 mln series A financing

* Cancer metabolism company Metabomed completes $18 million series A financing

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)